{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T18:37:04Z","timestamp":1793558224199,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,10,25]],"date-time":"2006-10-25T00:00:00Z","timestamp":1161734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1471-2334-6-155","type":"journal-article","created":{"date-parts":[[2006,10,25]],"date-time":"2006-10-25T14:15:16Z","timestamp":1161785716000},"source":"Crossref","is-referenced-by-count":20,"title":["Patterns of antimicrobial resistance in a surgical intensive care unit of a university hospital in Turkey"],"prefix":"10.1186","volume":"6","author":[{"given":"Aysen","family":"Bayram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iclal","family":"Balci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,25]]},"reference":[{"key":"419_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/clinids\/24.2.211","volume":"24","author":"L Archibald","year":"1997","unstructured":"Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R: Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis. 1997, 24: 211-215.","journal-title":"Clin Infect Dis"},{"key":"419_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3201\/eid0702.010206","volume":"7","author":"R Weinstein","year":"2001","unstructured":"Weinstein R: Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis. 2001, 7: 188-191.","journal-title":"Emerg Infect Dis"},{"key":"419_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijantimicag.2003.12.019","volume":"24","author":"JM Streit","year":"2004","unstructured":"Streit JM, Jones RN, Sader HS, Fritsche TR: Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents. 2004, 24: 111-118. 10.1016\/j.ijantimicag.2003.12.019.","journal-title":"Int J Antimicrob Agents"},{"key":"419_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3201\/eid0807.010427","volume":"8","author":"SK Fridkin","year":"2002","unstructured":"Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gaynes RR, McGowan JE: Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis. 2002, 8: 697-701.","journal-title":"Emerg Infect Dis"},{"key":"419_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1179\/joc.2002.14.1.25","volume":"14","author":"JA Garcia-Rodriguez","year":"2002","unstructured":"Garcia-Rodriguez JA, The MYSTIC Programme Study Group, Jones RN: Antimicrobial resistance in Gram-negative isolates from European intensive care units: data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme. J Chemother. 2002, 14: 25-32.","journal-title":"J Chemother"},{"key":"419_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7326\/0003-4819-135-3-200108070-00009","volume":"135","author":"SK Fridkin","year":"2001","unstructured":"Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, Gaynes RP, McGowan JE: The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med. 2001, 135: 175-183.","journal-title":"Ann Intern Med"},{"key":"419_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s100960100455","volume":"20","author":"AC Fluit","year":"2001","unstructured":"Fluit AC, Verhoef J, The European SENTRY Participants, Schmitz FJ: Frequency of isolation and antimicrobial resistance of Gram-negative and Gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997\u20131998. Eur J Clin Microbiol Infect Dis. 2001, 20: 617-625. 10.1007\/s100960100455.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"419_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.289.7.885","volume":"289","author":"MM Neuhauser","year":"2003","unstructured":"Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP: Antibiotic resistance among Gram-negative bacilli in US intensive care units. JAMA. 2003, 289: 885-888. 10.1001\/jama.289.7.885.","journal-title":"JAMA"},{"key":"419_CR9","first-page":"44","volume":"9","author":"C Mendes","year":"2005","unstructured":"Mendes C, Oplustil C, Sakagami E, Turner P, Kiffer C, The MYSTIC Brazil Group: Antimicrobial Susceptibility in Intensive Care Units: MYSTIC Program Brazil 2002. Brazilian J Infect Dis. 2005, 9: 44-51.","journal-title":"Brazilian J Infect Dis"},{"key":"419_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0732-8893(01)00321-2","volume":"41","author":"C Mendes","year":"2001","unstructured":"Mendes C, Turner PJ: Unit differences in pathogen occurrence arising from the MYSTIC program European database (1997\u20132000). Diagn Microbiol Infect Dis. 2001, 41: 191-196. 10.1016\/S0732-8893(01)00321-2.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"419_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0732-8893(01)00319-4","volume":"41","author":"MA Pfaller","year":"2001","unstructured":"Pfaller MA, Jones RN, Biedenbach DJ: Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA). Diagn Microbiol Infect Dis. 2001, 41: 177-182. 10.1016\/S0732-8893(01)00319-4.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"419_CR12","first-page":"595","volume":"29","author":"DJ Diekema","year":"1997","unstructured":"Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, Sader HS, Kugler K, Beach M: Survey of bloodstream infection due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the SENTRY Antimicrobial Surveillance Program 1997. Clin Infect Dis. 1997, 29: 595-607.","journal-title":"Clin Infect Dis"},{"key":"419_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0924-8579(99)00131-4","volume":"13","author":"DJ Diekema","year":"2000","unstructured":"Diekema DJ, Pfaller MA, Jones RN, Doern GV, Kugler K, Beach ML, Sader HS: Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infection in the USA, Canada and Latin America. SENTRY Participants Group. Int J Antimicrob Agents. 2000, 13: 257-271. 10.1016\/S0924-8579(99)00131-4.","journal-title":"Int J Antimicrob Agents"},{"key":"419_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0272-5231(05)70143-X","volume":"20","author":"SK Fridkin","year":"1999","unstructured":"Fridkin SK, Gaynes RP: Antimicrobial resistance in intensive care units. Clinics in Chest Medicine. 1999, 20: 303-316. 10.1016\/S0272-5231(05)70143-X.","journal-title":"Clinics in Chest Medicine"},{"key":"419_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3201\/eid0503.990301","volume":"5","author":"H Aubry-Damon","year":"1999","unstructured":"Aubry-Damon H, Courvalin P: Bacterial Resistance to Antimicrobial Agents: Selected Problems in France, 1996 to 1998. Emerg Infect Dis. 1999, 5: 315-320.","journal-title":"Emerg Infect Dis"},{"key":"419_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1179\/joc.2004.16.5.437","volume":"16","author":"I Friedland","year":"2004","unstructured":"Friedland I, Gallagher G, King T, Woods GL: Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States. J Chemother. 2004, 16: 437-441.","journal-title":"J Chemother"},{"key":"419_CR17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/clinids\/20.4.790","volume":"20","author":"O Lortholary","year":"1995","unstructured":"Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, Rosenzweig R, Gutmann L, Safar M, Acar J: Nosocomial acquisition of multi-resistant Acinetobacter baumannii: Risk factors and prognosis. Clin Infect Dis. 1995, 20: 790-796.","journal-title":"Clin Infect Dis"},{"key":"419_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1128\/AAC.37.4.750","volume":"37","author":"H Seifert","year":"1993","unstructured":"Seifert H, Baginski R, Schulze A, Pulverer G: Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother. 1993, 37: 750-753.","journal-title":"Antimicrob Agents Chemother"},{"key":"419_CR19","volume-title":"Principles and Practice of Infectious Diseases","author":"BI Eisenstein","year":"2000","unstructured":"Eisenstein BI, Zaleznik DF: Enterobacteriaceae. Principles and Practice of Infectious Diseases. Edited by: Mandell GL, Bennett JE, Dolin R. 2000, Churchill Livingstone"},{"key":"419_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0732-8893(97)00064-3","volume":"28","author":"MA Pfaller","year":"1997","unstructured":"Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, Wenzel RP: Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis. 1997, 28: 211-219. 10.1016\/S0732-8893(97)00064-3.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"419_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2307\/30141215","volume":"18","author":"DM Shlaes","year":"1997","unstructured":"Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C: Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 1997, 18: 275-291.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"419_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1086\/520193","volume":"29","author":"SK Fridkin","year":"1999","unstructured":"Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE, Archibald LK, Gaynes RP, Tenover FC: Surveillance of antimicrobial use and antimicrobial resistance in US hospital: project ICARE Phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis. 1999, 29: 245-252.","journal-title":"Clin Infect Dis"},{"key":"419_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00003246-199905000-00020","volume":"27","author":"MJ Richards","year":"1999","unstructured":"Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999, 27: 887-892. 10.1097\/00003246-199905000-00020.","journal-title":"Crit Care Med"},{"key":"419_CR24","volume-title":"NCCLS Wayne Pa","author":"NCCLS","year":"2003","unstructured":"NCCLS: Performance Standards for Antimicrobial Susceptibility Testing: eleventh informational supplement M100\u2013S13. NCCLS Wayne Pa. 2003"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-6-155\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-6-155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-6-155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-6-155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:34:26Z","timestamp":1548120866000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-6-155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-6-155","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,25]]},"article-number":"155"}}